Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
19.18
-0.02 (-0.10%)
Feb 24, 2026, 3:00 PM CST
SHA:688553 Revenue
Sichuan Huiyu Pharmaceutical had revenue of 288.63M CNY in the quarter ending September 30, 2025, a decrease of -9.70%. This brings the company's revenue in the last twelve months to 984.29M, down -12.10% year-over-year. In the year 2024, Sichuan Huiyu Pharmaceutical had annual revenue of 1.09B with 18.05% growth.
Revenue (ttm)
984.29M
Revenue Growth
-12.10%
P/S Ratio
8.22
Revenue / Employee
712.22K
Employees
1,331
Market Cap
8.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.09B | 167.31M | 18.05% |
| Dec 31, 2023 | 927.08M | -566.19M | -37.92% |
| Dec 31, 2022 | 1.49B | -330.47M | -18.12% |
| Dec 31, 2021 | 1.82B | 459.54M | 33.69% |
| Dec 31, 2020 | 1.36B | 657.12M | 92.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Cisen Pharmaceutical | 3.56B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Hainan Haiyao | 825.66M |